Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,048 | 29,149 | -708,373 | -530,113 | -499,938 |
| Depreciation Amortization | 14,974 | 7,473 | 48,842 | 37,999 | 25,549 |
| Income taxes - deferred | N/A | N/A | -89,895 | -89,992 | -22,989 |
| Accounts receivable | 619 | -4,206 | 9,180 | 14,476 | 6,708 |
| Accounts payable and accrued liabilities | -4,618 | -4,351 | -17,222 | -16,898 | -12,070 |
| Other Working Capital | -28,323 | -11,527 | -43,430 | -67,200 | -21,825 |
| Other Operating Activity | -122,945 | -125,859 | 432,610 | 346,954 | 349,213 |
| Operating Cash Flow | $-165,341 | $-109,321 | $-368,288 | $-304,774 | $-175,352 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -7 | -4,525 | -4,525 | -4,448 |
| Net Acquisitions | 166,383 | 166,383 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -131,560 | -131,560 | -131,560 |
| Sale Of Investment | N/A | N/A | 131,535 | 89,344 | N/A |
| Investing Cash Flow | $166,376 | $166,376 | $-4,550 | $-46,741 | $-136,008 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -55,000 | -55,000 | -54,997 |
| Common Stock Issued | 11,913 | 8,683 | 48,619 | 40,708 | 35,859 |
| Other Financing Activity | -511 | -171 | -10,690 | -10,286 | -9,732 |
| Financing Cash Flow | $11,402 | $8,512 | $-17,071 | $-24,578 | $-28,870 |
| Exchange Rate Effect | -1,374 | -962 | -58 | 1,008 | 818 |
| Beginning Cash Position | 156,900 | 156,900 | 546,867 | 546,867 | 546,867 |
| End Cash Position | 167,963 | 221,505 | 156,900 | 171,782 | 207,455 |
| Net Cash Flow | $11,063 | $64,605 | $-389,967 | $-375,085 | $-339,412 |
| Free Cash Flow | |||||
| Operating Cash Flow | -165,341 | -109,321 | -368,288 | -304,774 | -175,352 |
| Capital Expenditure | -7 | -7 | -4,525 | -4,525 | -4,448 |
| Free Cash Flow | -165,348 | -109,328 | -372,813 | -309,299 | -179,800 |